Department of Pharmacology, School of Medicine, National Yang-Ming University, Taiwan, ROC.
J Ethnopharmacol. 2011 Apr 12;134(3):884-91. doi: 10.1016/j.jep.2011.01.056. Epub 2011 Feb 4.
S/B remedy prepared from Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd, two herbals of Xiao-Tsai-Hu-Tang or Sho-Saiko-To (TJ-9), contains active flavonoids. In this study, the protective effect of S/B remedy on iron-induced neurodegeneration was investigated in the nigrostriatal dopaminergic system of rat brain.
The antioxidative activity of S/B remedy was studied using brain homogenates incubated with ferrous citrate (iron, 1M), S/B remedy, Trolox and melatonin. Furthermore, a Parkinsonian animal model by an intranigral infusion of iron in the anesthetized rats was employed to investigate the protective effect of S/B remedy in the nigrostriatal dopaminergic system.
Our in vitro studies showed that S/B remedy was more potent than melatonin and equal to trolox in inhibiting iron-induced lipid peroxidation of brain homogenates. Our in vivo studies found that oral administration of S/B remedy dose-dependently attenuated iron-elevated lipid peroxidation in the infused substantia nigra (SN) and iron-depleted dopamine levels in the ipsilateral striatum. Furthermore, iron-induced reductions in glutathione (GSH) content and increases in GSSG (oxidized GSH)/GSH ratio in the infused SN were inhibited in S/B remedy-treated rats. Systemic S/B remedy attenuated the iron-induced increases in heme-oxygenase-1 levels and α-synuclein aggregation in the infused SN. Moreover, S/B remedy reduced iron-induced apoptosis via attenuating mitochondrial and endoplasmic reticulum stress. In addition, S/B remedy was anti-inflammatory as indicated by the attenuation of iron-induced elevations in inducible nitric oxide synthase and cyclo-oxygenase II levels as well as glial fibrillary acidic protein (a biological marker of astrocytes) and ED-1 (a protein indicative of activated microglia) levels in the infused SN of S/B remedy-treated rats.
These findings suggest that oral administration of S/B remedy is protective against iron-induced neurodegeneration in the nigrostriatal dopaminergic system of rat brain. Therefore, S/B remedy may be therapeutically useful for the treatment of CNS neurodegenerative diseases.
小柴胡汤或柴芍六君子汤(TJ-9)的两种草药黄芩和柴胡,制成的 S/B 制剂含有活性黄酮类化合物。本研究旨在探讨 S/B 制剂对大鼠脑黑质纹状体多巴胺能系统中铁诱导神经退行性变的保护作用。
采用脑匀浆与柠檬酸亚铁(铁,1M)、S/B 制剂、Trolox 和褪黑素孵育的方法研究 S/B 制剂的抗氧化活性。此外,还采用麻醉大鼠黑质内铁输注建立帕金森病动物模型,研究 S/B 制剂对黑质纹状体多巴胺能系统的保护作用。
我们的体外研究表明,S/B 制剂抑制脑匀浆铁诱导的脂质过氧化作用强于褪黑素,与 Trolox 相当。我们的体内研究发现,S/B 制剂口服给药可剂量依赖性减轻铁升高的纹状体中脂质过氧化作用和铁耗竭的多巴胺水平。此外,S/B 制剂还可抑制铁诱导的注入 SN 中谷胱甘肽(GSH)含量降低和 GSSG(氧化 GSH)/GSH 比值升高。S/B 制剂还可减轻铁诱导的注入 SN 中血红素加氧酶-1 水平升高和α-突触核蛋白聚集。此外,S/B 制剂通过减轻线粒体和内质网应激,减少铁诱导的细胞凋亡。此外,S/B 制剂具有抗炎作用,可减轻铁诱导的诱导型一氧化氮合酶和环氧化酶 II 水平升高以及胶质纤维酸性蛋白(星形胶质细胞的生物标志物)和 ED-1(激活小胶质细胞的蛋白)水平升高。
这些发现表明,S/B 制剂口服给药可预防大鼠脑黑质纹状体多巴胺能系统中铁诱导的神经退行性变。因此,S/B 制剂可能对 CNS 神经退行性疾病的治疗有治疗作用。